Driver of cystic fibrosis lung inflammation yields target for treatment


Yale researchers have identified a possible driver of the persistent inflammation that causes irreversible lung damage in patients with cystic fibrosis, a genetic disorder that impairs breathing and digestion.

‘Spider-Man: Across the Spider-Verse’ trailer teases a multiversal Spider brawl

Previous article

Telehealth navigator program ups video visit adherence in primary care

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Innovations